🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2007-08
Trial ID
NCT00544804
Treatments Being Tested
Background: Complete overdenture manufacturing has been greatly developed u...
Status
Completed
Location
Mansoura university
Start Date
2022-01-15
Trial ID
NCT06166446
Treatments Being Tested
RATIONALE: Pemetrexed may stop the growth of tumor cells by blocking some o...
Status
Completed
Location
Centre Oscar Lambret
Start Date
2007-06
Trial ID
NCT00541073
RATIONALE: Identifying gene mutations and other risk factors in patients wi...
Status
Unknown
Location
Leeds Cancer Centre at St. James's University Hospital
Start Date
1989-01
Trial ID
NCT00450593
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
RATIONALE: Genetic studies may help in understanding the genetic processes ...
Status
Completed
Location
UCSF Cancer Center and Cancer Research Institute
Start Date
2001-03
Trial ID
NCT00010114
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Unknown
Location
Cancer Research UK at Cambridge Research Institute
Start Date
2008-09
Trial ID
NCT00967954
RATIONALE: Biological therapies, such as GM-CSF, may stimulate the immune s...
Status
Unknown
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00893477
Next Generation Sequencing in cancer: a feasibility study in France to asse...
Status
Completed
Location
Institut Bergonié
Start Date
2017-05-23
Trial ID
NCT03546127
Treatments Being Tested